Collaboration of RON and epidermal growth factor receptor in human bladder carcinogenesis

Pei-Yin Hsu1, Hsiao-Sheng Liu, Hong-Lin Cheng

  • 1Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan, Republic of China.

The Journal of Urology
|October 31, 2006
PubMed
Abstract

Insights

Epidermal growth factor receptor (EGFR) and RON receptor tyrosine kinase collaborate in bladder cancer progression. Inhibiting EGFR blocks RON-driven tumor growth, invasion, and recurrence, suggesting combined targeting for improved patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Receptor tyrosine kinases (RTKs) play crucial roles in cancer development.
  • RON, a specific RTK, is implicated in human bladder carcinogenesis.
  • Cross-talk between RTKs, like EGFR and RON, is a key mechanism in tumor progression.

Purpose of the Study:

  • To investigate the significance of epidermal growth factor receptor (EGFR) in modulating RON-associated bladder tumorigenesis.
  • To elucidate the biological impact of the collaboration between RON and EGFR in bladder cancer.
  • To assess the clinical relevance of RON and EGFR co-expression in a bladder cancer patient cohort.

Main Methods:

  • Examined RON-EGFR interaction in bladder cancer cell lines (TSGH8301, J82, JR) using immunoprecipitation and immunoblotting.
  • Assessed cell migration via time-lapse wound healing and Transwell assays.
  • Analyzed cell transformation using foci formation assays.
  • Investigated clinical significance through immunohistochemistry in a cohort of 78 bladder cancer patients.

Main Results:

  • EGFR directly associates with RON, independent of ligand stimulation.
  • EGFR inhibition (siRNA or kinase inhibitors) suppressed RON-driven mitogenesis, migration, anti-apoptosis, and neoplastic transformation.
  • Co-expression of RON and EGFR was observed in 33.3% of patients (26/78).
  • RON/EGFR co-expression correlated significantly with tumor invasion, local recurrence risk, and decreased patient survival.
  • Combined RON/EGFR expression and tumor staging were critical indicators of patient survival.

Conclusions:

  • A functional cross-talk exists between EGFR and RON in bladder cancer in vivo.
  • The EGFR-RON axis represents a potential therapeutic target for bladder cancer.
  • Considering this interaction in treatment planning may improve outcomes for bladder cancer patients.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...